High-plasma soluble prorenin receptor is associated with vascular damage in male, but not female, mice fed a high-fat diet.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 06 2023
Historique:
pmc-release: 01 06 2024
medline: 27 4 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Plasma soluble prorenin receptor (sPRR) displays sexual dimorphism and is higher in women with type 2 diabetes mellitus (T2DM). However, the contribution of plasma sPRR to the development of vascular complications in T2DM remains unclear. We investigated if plasma sPRR contributes to sex differences in the activation of the systemic renin-angiotensin-aldosterone system (RAAS) and vascular damage in a model of high-fat diet (HFD)-induced T2DM. Male and female C57BL/6J mice were fed either a normal fat diet (NFD) or an HFD for 28 wk to assess changes in blood pressure, cardiometabolic phenotype, plasma prorenin/renin, sPRR, and ANG II. After completing dietary protocols, tissues were collected from males to assess vascular reactivity and aortic reactive oxygen species (ROS). A cohort of male mice was used to determine the direct contribution of increased systemic sPRR by infusion. To investigate the role of ovarian hormones, ovariectomy (OVX) was performed at 32 wk in females fed either an NFD or HFD. Significant sex differences were found after 28 wk of HFD, where only males developed T2DM and increased plasma prorenin/renin, sPRR, and ANG II. T2DM in males was accompanied by nondipping hypertension, carotid artery stiffening, and aortic ROS. sPRR infusion in males induced vascular thickening instead of material stiffening caused by HFD-induced T2DM. While intact females were less prone to T2DM, OVX increased plasma prorenin/renin, sPRR, and systolic blood pressure. These data suggest that sPRR is a novel indicator of systemic RAAS activation and reflects the onset of vascular complications during T2DM regulated by sex.

Identifiants

pubmed: 36930656
doi: 10.1152/ajpheart.00638.2022
pmc: PMC10151046
doi:

Substances chimiques

Renin EC 3.4.23.15
Prorenin Receptor 0
Reactive Oxygen Species 0
N-formyl-13-dihydrocarminomycin 76634-96-3
Receptors, Cell Surface 0
Vacuolar Proton-Translocating ATPases EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

H762-H775

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL133619
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL155841
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL155841
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM103337
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK104375
Pays : United States

Références

J Diabetes Complications. 2020 Feb;34(2):107448
pubmed: 31761419
PLoS One. 2011;6(8):e23337
pubmed: 21829729
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Curr Hypertens Rep. 2008 Apr;10(2):93-8
pubmed: 18474174
Hypertension. 2021 Feb;77(2):405-416
pubmed: 33280408
Placenta. 2016 Jan;37:72-8
pubmed: 26684753
J Hypertens. 1998 Jun;16(6):853-62
pubmed: 9663926
Hypertension. 2013 Jul;62(1):78-84
pubmed: 23690347
Chronobiol Int. 2013 Mar;30(1-2):99-115
pubmed: 23098178
Biol Sex Differ. 2021 May 1;12(1):33
pubmed: 33933156
Hypertension. 2006 Jul;48(1):65-72
pubmed: 16702491
Hypertens Res. 2011 May;34(5):599-605
pubmed: 21270819
Hypertension. 2016 Jul;68(1):213-9
pubmed: 27185751
Am J Physiol Endocrinol Metab. 2021 Mar 1;320(3):E609-E618
pubmed: 33459178
J Clin Invest. 2002 Jun;109(11):1417-27
pubmed: 12045255
Am J Physiol Heart Circ Physiol. 2014 Aug 15;307(4):H493-503
pubmed: 24929852
J Hypertens. 2010 Aug;28(8):1692-8
pubmed: 20647860
Acta Physiol Scand. 1993 Sep;149(1):91-7
pubmed: 8237427
JCI Insight. 2020 Apr 9;5(7):
pubmed: 32271168
Vascul Pharmacol. 2012 Nov-Dec;57(5-6):187-93
pubmed: 22885305
Curr Cardiovasc Risk Rep. 2015;9(7):36
pubmed: 26029318
JCI Insight. 2022 Oct 10;7(19):
pubmed: 35998033
Front Biosci (Landmark Ed). 2020 Jun 1;25(10):1839-1853
pubmed: 32472760
Hypertension. 2011 Mar;57(3):397-405
pubmed: 21263119
J Hum Hypertens. 2022 Nov 1;:
pubmed: 36319856
Clin Sci (Lond). 2021 Mar 26;135(6):793-810
pubmed: 33625485
Hypertension. 2011 Apr;57(4):859-64
pubmed: 21321306
Inflamm Res. 2003 May;52(5):191-8
pubmed: 12813623
Diabetologia. 2012 Nov;55(11):3104-13
pubmed: 22930161
Physiol Rev. 2001 Jul;81(3):999-1030
pubmed: 11427690
Sci Rep. 2016 Apr 25;6:25053
pubmed: 27109832
Free Radic Biol Med. 2018 May 1;119:108-114
pubmed: 29198725
Hypertens Res. 2021 Jun;44(6):674-684
pubmed: 33564180
Am J Hypertens. 1994 Aug;7(8):723-30
pubmed: 7986463
Clin Sci (Lond). 1989 Apr;76(4):439-46
pubmed: 2523771
Endocrinology. 2006 Dec;147(12):5826-34
pubmed: 16959846
Am J Hypertens. 2015 Oct;28(10):1187-96
pubmed: 25890829
Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F305-F311
pubmed: 28153915
Hypertens Res. 2014 Sep;37(9):830-5
pubmed: 24830537
Hypertension. 2012 Nov;60(5):1250-6
pubmed: 23045457
Am J Physiol Renal Physiol. 2013 Mar 1;304(5):F505-14
pubmed: 23303412
Clin J Am Soc Nephrol. 2014 Jul;9(7):1163-7
pubmed: 24742480
Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H506-H515
pubmed: 30550352
Hypertension. 2019 Oct;74(4):1014-1020
pubmed: 31378099
Nat Rev Nephrol. 2021 Jul;17(7):481-492
pubmed: 33824491
Ann Biomed Eng. 2013 Jul;41(7):1311-30
pubmed: 23549898
FASEB J. 2022 Apr;36(4):e22237
pubmed: 35226776
Endocrinology. 2009 May;150(5):2109-17
pubmed: 19164473
J Clin Invest. 2004 Oct;114(8):1128-35
pubmed: 15489960
J Endocrinol. 2012 Jan;212(1):61-9
pubmed: 21965546
Circ Res. 2021 Jun 25;129(1):50-62
pubmed: 33890822
Clin Exp Hypertens A. 1986;8(2):153-66
pubmed: 3521953
Hypertension. 2009 Jun;53(6):1077-82
pubmed: 19380613
Front Endocrinol (Lausanne). 2019 Aug 27;10:586
pubmed: 31507536
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Diabetologia. 2012 Jun;55(6):1847-55
pubmed: 22411135
Nephrol Dial Transplant. 1999 Aug;14(8):1904-11
pubmed: 10462269
Am J Physiol Cell Physiol. 2013 Sep;305(5):C547-57
pubmed: 23804203
N Engl J Med. 1985 May 30;312(22):1412-7
pubmed: 3887168
Basic Res Cardiol. 2011 Nov;106(6):1123-34
pubmed: 21744279
Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H139-H145
pubmed: 29101170
Clin Exp Hypertens A. 1990;12(8):1405-17
pubmed: 2081373
Int J Mol Med. 2006 Sep;18(3):483-8
pubmed: 16865234
Hypertension. 1995 Aug;26(2):337-40
pubmed: 7635544
Clin Exp Hypertens. 2008 Oct;30(7):585-97
pubmed: 18855262
Am J Physiol Heart Circ Physiol. 2022 Aug 1;323(2):H336-H349
pubmed: 35749718
Front Cardiovasc Med. 2020 Feb 25;7:22
pubmed: 32158768
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F456-F462
pubmed: 31241989
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Ann Biomed Eng. 2015 Nov;43(11):2760-70
pubmed: 25986954
Lancet. 2014 Jun 7;383(9933):1973-80
pubmed: 24613026
Biol Sex Differ. 2019 Jul 1;10(1):31
pubmed: 31262355
Pflugers Arch. 2013 Jan;465(1):87-97
pubmed: 22543358
Arq Bras Cardiol. 2014 Feb;102(2):157-63
pubmed: 24676371
Hypertension. 2021 Jul;78(1):e1-e14
pubmed: 34024124
Hypertens Res. 2014 Jul;37(7):642-8
pubmed: 24646643
J Appl Physiol (1985). 2012 Oct;113(7):1128-40
pubmed: 22837170
Anal Quant Cytol Histol. 2001 Aug;23(4):291-9
pubmed: 11531144
J Nephrol. 2010 Sep-Oct;23(5):508-13
pubmed: 20383869
Obesity (Silver Spring). 2014 Oct;22(10):2201-9
pubmed: 25044950
Hypertension. 2012 Dec;60(6):1524-30
pubmed: 23108647
Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1066-75
pubmed: 26078188
J Appl Physiol (1985). 2009 Oct;107(4):1328-38
pubmed: 19679741
Hypertension. 2014 Feb;63(2):297-302
pubmed: 24218434
J Biochem. 2017 Apr 1;161(4):369-379
pubmed: 28013223
Atherosclerosis. 2018 Mar;270:123-131
pubmed: 29407880
Diabetologia. 1999 Aug;42(8):1006-10
pubmed: 10491762

Auteurs

Bruna Visniauskas (B)

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Tulane Center for Sex-Based Biology and Medicine, New Orleans, Louisiana, United States.

Virginia Reverte (V)

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Caleb M Abshire (CM)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Benard O Ogola (BO)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.

Carla B Rosales (CB)

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Michelle Galeas-Pena (M)

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Venkata N Sure (VN)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Siva S V P Sakamuri (SSVP)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Nicholas R Harris (NR)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Isabella Kilanowski-Doroh (I)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Alexandra B Mcnally (AB)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Alec C Horton (AC)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Margaret Zimmerman (M)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Prasad V G Katakam (PVG)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.

Sarah H Lindsey (SH)

Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Tulane Center for Sex-Based Biology and Medicine, New Orleans, Louisiana, United States.
Tulane Hypertension and Renal Center of Excellence, New Orleans, Louisiana, United States.

Minolfa C Prieto (MC)

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Tulane Center for Sex-Based Biology and Medicine, New Orleans, Louisiana, United States.
Tulane Hypertension and Renal Center of Excellence, New Orleans, Louisiana, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH